562 related articles for article (PubMed ID: 18470859)
1. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
[TBL] [Abstract][Full Text] [Related]
2. Antimalarial activity of methylpiperazinyl-substituted benzophenone-based farnesyltransferase inhibitors.
Kettler K; Wiesner J; Ortmann R; Dahse HM; Jomaa H; Schlitzer M
Pharmazie; 2006 Jan; 61(1):63-5. PubMed ID: 16454209
[No Abstract] [Full Text] [Related]
3. 2-(aminoacylamino)benzophenones: farnesyltransferase inhibition and antimalarial activity.
Kettler K; Wiesner J; Fucik K; Sakowski J; Ortmann R; Dahse HM; Jomaa H; Schlitzer M
Pharmazie; 2005 Sep; 60(9):677-82. PubMed ID: 16222868
[TBL] [Abstract][Full Text] [Related]
4. Non-thiol farnesyltransferase inhibitors: N-(4-aminoacylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2 furyl]acrylic acid amides and their antimalarial activity.
Kettler K; Wiesner J; Silber K; Haebel P; Ortmann R; Sattler I; Dahse HM; Jomaa H; Klebe G; Schlitzer M
Eur J Med Chem; 2005 Jan; 40(1):93-101. PubMed ID: 15642414
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of novel anti-malarial agents part 8. Effect of different central aryls in biarylacryloylaminobenzophenones on antimalarial activity.
Wiesner J; Mitsch A; Altenkämper M; Ortmann R; Jomaa H; Schlitzer M
Pharmazie; 2003 Dec; 58(12):854-6. PubMed ID: 14703959
[TBL] [Abstract][Full Text] [Related]
6. 2-Acylamino-5-chlorobenzophenones with enhanced selectivity towards malaria parasites.
Heinrich S; Altenkämper M; Bechem B; Perruchon J; Ortmann R; Dahse HM; Wang Y; Lanzer M; Schlitzer M
Eur J Med Chem; 2011 Apr; 46(4):1331-42. PubMed ID: 21345543
[TBL] [Abstract][Full Text] [Related]
7. Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
Mitsch A; Bergemann S; Gust R; Sattler I; Schlitzer M
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):242-50. PubMed ID: 12916059
[TBL] [Abstract][Full Text] [Related]
8. Benzophenone-based farnesyltransferase inhibitors with high activity against Trypanosoma cruzi.
Esteva MI; Kettler K; Maidana C; Fichera L; Ruiz AM; Bontempi EJ; Andersson B; Dahse HM; Haebel P; Ortmann R; Klebe G; Schlitzer M
J Med Chem; 2005 Nov; 48(23):7186-91. PubMed ID: 16279776
[TBL] [Abstract][Full Text] [Related]
9. Structurally simple farnesyltransferase inhibitors arrest the growth of malaria parasites.
Glenn MP; Chang SY; Hucke O; Verlinde CL; Rivas K; Hornéy C; Yokoyama K; Buckner FS; Pendyala PR; Chakrabarti D; Gelb M; Van Voorhis WC; Sebti SM; Hamilton AD
Angew Chem Int Ed Engl; 2005 Aug; 44(31):4903-6. PubMed ID: 16007716
[No Abstract] [Full Text] [Related]
10. Inhibitors of farnesyltransferase: 5-arylacryloylaminobenzophenones show antimalarial activity.
Wiesner J; Ortmann R; Mitsch A; Wissner P; Sattler I; Jomaa H; Schlitzer M
Pharmazie; 2003 Apr; 58(4):289-90. PubMed ID: 12749417
[No Abstract] [Full Text] [Related]
11. In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability.
Carrico D; Ohkanda J; Kendrick H; Yokoyama K; Blaskovich MA; Bucher CJ; Buckner FS; Van Voorhis WC; Chakrabarti D; Croft SL; Gelb MH; Sebti SM; Hamilton AD
Bioorg Med Chem; 2004 Dec; 12(24):6517-26. PubMed ID: 15556768
[TBL] [Abstract][Full Text] [Related]
12. Non-thiol farnesyltransferase inhibitors: utilization of the far aryl binding site by 5-cinnamoylaminobenzophenones.
Mitsch A; Wissner P; Böhm M; Silber K; Klebe G; Sattler I; Schlitzer M
Arch Pharm (Weinheim); 2004 Sep; 337(9):493-501. PubMed ID: 15362122
[TBL] [Abstract][Full Text] [Related]
13. 2-(Arylpropionylamino)- and 2-(arylacryloylamino)benzophenones: farnesyltransferase inhibition and antimalarial activity.
Fucik K; Kettler K; Wiesner J; Ortmann R; Unterreitmeier D; Krauss J; Bracher F; Jomaa H; Schlitzer M
Pharmazie; 2004 Oct; 59(10):744-52. PubMed ID: 15544051
[TBL] [Abstract][Full Text] [Related]
14. Antimalarial and antitrypanosomal activity of a series of amide and sulfonamide derivatives of a 2,5-diaminobenzophenone.
Altenkämper M; Bechem B; Perruchon J; Heinrich S; Mädel A; Ortmann R; Dahse HM; Freunscht E; Wang Y; Rath J; Stich A; Hitzler M; Chiba P; Lanzer M; Schlitzer M
Bioorg Med Chem; 2009 Nov; 17(22):7690-7. PubMed ID: 19819706
[TBL] [Abstract][Full Text] [Related]
15. Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.
Nallan L; Bauer KD; Bendale P; Rivas K; Yokoyama K; Hornéy CP; Pendyala PR; Floyd D; Lombardo LJ; Williams DK; Hamilton A; Sebti S; Windsor WT; Weber PC; Buckner FS; Chakrabarti D; Gelb MH; Van Voorhis WC
J Med Chem; 2005 Jun; 48(11):3704-13. PubMed ID: 15916422
[TBL] [Abstract][Full Text] [Related]
16. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
17. Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapy.
Mukherjee P; Pradhan A; Shah F; Tekwani BL; Avery MA
Bioorg Med Chem; 2008 May; 16(9):5254-65. PubMed ID: 18362073
[TBL] [Abstract][Full Text] [Related]
18. Second generation tetrahydroquinoline-based protein farnesyltransferase inhibitors as antimalarials.
Bendale P; Olepu S; Suryadevara PK; Bulbule V; Rivas K; Nallan L; Smart B; Yokoyama K; Ankala S; Pendyala PR; Floyd D; Lombardo LJ; Williams DK; Buckner FS; Chakrabarti D; Verlinde CL; Van Voorhis WC; Gelb MH
J Med Chem; 2007 Sep; 50(19):4585-605. PubMed ID: 17722901
[TBL] [Abstract][Full Text] [Related]
19. 3D-QSAR with the aid of pharmacophore search and docking-based alignments for farnesyltransferase inhibitors.
Vaidya M; Weigt M; Wiese M
Eur J Med Chem; 2009 Oct; 44(10):4070-82. PubMed ID: 19515462
[TBL] [Abstract][Full Text] [Related]
20. Acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase.
Nguyen C; Ruda GF; Schipani A; Kasinathan G; Leal I; Musso-Buendia A; Kaiser M; Brun R; Ruiz-Pérez LM; Sahlberg BL; Johansson NG; Gonzalez-Pacanowska D; Gilbert IH
J Med Chem; 2006 Jul; 49(14):4183-95. PubMed ID: 16821778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
